HELX icon

Franklin Genomic Advancements ETF

28.10 USD
+0.02
0.07%
Updated Jul 30, 3:52 PM EDT
1 day
0.07%
5 days
-1.65%
1 month
1.41%
3 months
3.16%
6 months
-8.97%
Year to date
-3.17%
1 year
-16.04%
5 years
-17.79%
10 years
17.28%
0
Funds holding %
of 7,323 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

0% more funds holding

Funds holding: 8 [Q4 2024] → 8 (+0) [Q1 2025]

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

2.48% less ownership

Funds ownership: 22.9% [Q4 2024] → 20.42% (-2.48%) [Q1 2025]

26% less capital invested

Capital invested by funds: $2.97M [Q4 2024] → $2.21M (-$767K) [Q1 2025]

Research analyst outlook

We haven’t received any recent analyst ratings for HELX.

Financial journalist opinion

Charts implemented using Lightweight Charts™